Cargando…
CAR T Cell Therapy for Chronic Lymphocytic Leukemia: Successes and Shortcomings
Chimeric antigen receptor T (CAR T) cell therapy achieved remarkable success in B-cell leukemia and lymphoma which led to its incorporation in treatment protocols for these diseases. CAR T cell therapy for chronic lymphocytic leukemia (CLL) patients showed less success compared to other malignant tu...
Autores principales: | Todorovic, Zeljko, Todorovic, Dusan, Markovic, Vladimir, Ladjevac, Nevena, Zdravkovic, Natasa, Djurdjevic, Predrag, Arsenijevic, Nebojsa, Milovanovic, Marija, Arsenijevic, Aleksandar, Milovanovic, Jelena |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9139644/ https://www.ncbi.nlm.nih.gov/pubmed/35621683 http://dx.doi.org/10.3390/curroncol29050293 |
Ejemplares similares
-
Shikonin Derivatives from Onsoma visianii Decrease Expression of Phosphorylated STAT3 in Leukemia Cells and Exert Antitumor Activity
por: Todorovic, Zeljko, et al.
Publicado: (2021) -
Galectin-3, Possible Role in Pathogenesis of Periodontal Diseases and Potential Therapeutic Target
por: Velickovic, Milica, et al.
Publicado: (2021) -
The Role of IL-17 in the Pathogenesis of Oral Squamous Cell Carcinoma
por: Ladjevac, Nevena, et al.
Publicado: (2023) -
Galectin-3 in Inflammasome Activation and Primary Biliary Cholangitis Development
por: Arsenijevic, Aleksandar, et al.
Publicado: (2020) -
Nanoparticles in Antiviral Therapy
por: Milovanovic, Marija, et al.
Publicado: (2017)